S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

Adient Stock Forecast, Price & News

-1.39 (-3.81 %)
(As of 01/15/2021 12:00 AM ET)
Today's Range
Now: $35.11
50-Day Range
MA: $35.26
52-Week Range
Now: $35.11
Volume951,544 shs
Average Volume649,495 shs
Market Capitalization$3.30 billion
P/E RatioN/A
Dividend YieldN/A
Adient plc designs, manufactures, and markets a range of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's products include frames, mechanisms, foams, head restraints, armrests, and trim covers. It serves automotive original equipment manufacturers in the Americas, Europe, China, and internationally. The company was incorporated in 2016 and is based in Dublin, Ireland.
Adient logo


Overall MarketRank

1.84 out of 5 stars

Auto/Tires/Trucks Sector

19th out of 128 stocks

Motor Vehicle Parts & Accessories Industry

10th out of 50 stocks

Analyst Opinion: 2.2Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 3.1 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Motor vehicle parts & accessories



Sales & Book Value

Annual Sales$12.67 billion
Cash Flow$3.37 per share
Book Value$16.35 per share


Net Income$-547,000,000.00


Market Cap$3.30 billion
Next Earnings Date2/5/2021 (Confirmed)
-1.39 (-3.81 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ADNT News and Ratings via Email

Sign-up to receive the latest news and ratings for ADNT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Adient (NYSE:ADNT) Frequently Asked Questions

How has Adient's stock been impacted by COVID-19 (Coronavirus)?

Adient's stock was trading at $16.45 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ADNT shares have increased by 113.4% and is now trading at $35.11.
View which stocks have been most impacted by COVID-19

Is Adient a buy right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Adient in the last twelve months. There are currently 2 sell ratings, 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Adient stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ADNT, but not buy additional shares or sell existing shares.
View analyst ratings for Adient
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Adient?

Wall Street analysts have given Adient a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Adient wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Adient's next earnings date?

Adient is scheduled to release its next quarterly earnings announcement on Friday, February 5th 2021.
View our earnings forecast for Adient

How can I listen to Adient's earnings call?

Adient will be holding an earnings conference call on Friday, February 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Adient's earnings last quarter?

Adient plc (NYSE:ADNT) posted its quarterly earnings results on Sunday, November, 29th. The company reported $1.15 EPS for the quarter, beating the Zacks' consensus estimate of $0.96 by $0.19. The business earned $3.60 billion during the quarter, compared to analysts' expectations of $3.61 billion. Adient had a negative net margin of 4.32% and a negative return on equity of 0.23%. During the same quarter last year, the company posted $0.63 earnings per share.
View Adient's earnings history

What guidance has Adient issued on next quarter's earnings?

Adient updated its FY 2021 Pre-Market earnings guidance on Monday, November, 30th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $14.6-15 billion, compared to the consensus revenue estimate of $14.47 billion.

What price target have analysts set for ADNT?

12 equities research analysts have issued 12-month price targets for Adient's stock. Their forecasts range from $16.00 to $45.00. On average, they anticipate Adient's share price to reach $31.33 in the next year. This suggests that the stock has a possible downside of 10.8%.
View analysts' price targets for Adient
or view Wall Street analyst' top-rated stocks.

Who are some of Adient's key competitors?

What other stocks do shareholders of Adient own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Adient investors own include Johnson Controls International (JCI), AT&T (T), Exxon Mobil (XOM), Cisco Systems (CSCO), AbbVie (ABBV), NVIDIA (NVDA), Intel (INTC), Pfizer (PFE), Ford Motor (F) and Johnson & Johnson (JNJ).

Who are Adient's key executives?

Adient's management team includes the following people:
  • Mr. Douglas G. Del Grosso, Pres, CEO & Director (Age 58, Pay $4.11M)
  • Mr. Jeffrey M. Stafeil, Exec. VP & CFO (Age 50, Pay $1.86M)
  • Mr. Jerome J. Dorlack, Exec. VP of Americas (Age 39, Pay $1.62M)
  • Mr. Jian James Huang, Exec. VP of Asia (Age 59, Pay $1.17M)
  • Mr. Gregory Scott Smith, VP & Chief Accounting Officer (Age 52)
  • Mr. Mark Oswald, VP of Investor Relations
  • Ms. Heather M. Tiltmann, Sr. VP, Gen. Counsel & Sec. (Age 48)
  • Ms. Renee McLeod, VP & CHRO
  • Ms. Kelli E. Carney, Chief Purchasing Officer & VP
  • Mr. Michel Pierre-Rose Berthelin, Exec. VP of EMEA

What is Adient's stock symbol?

Adient trades on the New York Stock Exchange (NYSE) under the ticker symbol "ADNT."

Who are Adient's major shareholders?

Adient's stock is owned by a number of institutional and retail investors. Top institutional investors include State of Alaska Department of Revenue (0.02%), Crossmark Global Holdings Inc. (0.01%) and Diversified Trust Co (0.01%). Company insiders that own Adient stock include Gregory Scott Smith, Jeffrey Stafeil and Jerome J Dorlack.
View institutional ownership trends for Adient

Which institutional investors are selling Adient stock?

ADNT stock was sold by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc., and State of Alaska Department of Revenue.
View insider buying and selling activity for Adient
or view top insider-selling stocks.

Which institutional investors are buying Adient stock?

ADNT stock was purchased by a variety of institutional investors in the last quarter, including Diversified Trust Co. Company insiders that have bought Adient stock in the last two years include Gregory Scott Smith, Jeffrey Stafeil, and Jerome J Dorlack.
View insider buying and selling activity for Adient
or or view top insider-buying stocks.

How do I buy shares of Adient?

Shares of ADNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Adient's stock price today?

One share of ADNT stock can currently be purchased for approximately $35.11.

How big of a company is Adient?

Adient has a market capitalization of $3.30 billion and generates $12.67 billion in revenue each year. The company earns $-547,000,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. Adient employs 77,000 workers across the globe.

What is Adient's official website?

The official website for Adient is www.adient.com.

How can I contact Adient?

Adient's mailing address is 49200 Halyard Drive, Plymouth MI, 48170. The company can be reached via phone at 734-254-5000.

This page was last updated on 1/17/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.